{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:27:33Z","timestamp":1793910453481,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jiph.2025.102711","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:50:43Z","timestamp":1740099043000},"page":"102711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-5303","authenticated-orcid":false,"given":"Van-Dong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6553-3276","authenticated-orcid":false,"given":"Hai","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9733-5899","authenticated-orcid":false,"given":"Wei-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2644-0694","authenticated-orcid":false,"given":"Hsiao-En","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-366X","authenticated-orcid":false,"given":"Jann-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1492-3044","authenticated-orcid":false,"given":"Chih-Hsin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccm.2014.10.003","article-title":"Environmental sources of nontuberculous mycobacteria","volume":"36","author":"Falkinham","year":"2015","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1016\/j.jiph.2025.102711_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2025.102711_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3348\/kjr.2002.3.3.145","article-title":"Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients","volume":"3","author":"Koh","year":"2002","journal-title":"Korean J Radiol"},{"issue":"4","key":"10.1016\/j.jiph.2025.102711_bib4","first-page":"285","article-title":"Nontuberculous mycobacteria in patients with human immunodeficiency virus infection","volume":"11","author":"Benator","year":"1996","journal-title":"Semin Respir Infect"},{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin chest Med"},{"issue":"7","key":"10.1016\/j.jiph.2025.102711_bib6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/cid\/ciaa252","article-title":"Variability in the management of adults with pulmonary nontuberculous mycobacterial disease","volume":"72","author":"Abate","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102711_bib7","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.jiph.2025.102711_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/cid\/cix517","article-title":"Treatment outcomes of mycobacterium avium complex lung disease: a systematic review and meta-analysis","volume":"65","author":"Kwak","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102711_bib9","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/jac\/dkx311","article-title":"Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease","volume":"72","author":"Pasipanodya","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jiph.2025.102711_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14787210.2020.1720650","article-title":"Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis","volume":"18","author":"Nasiri","year":"2020","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.jiph.2025.102711_bib11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2025.102711_bib12","unstructured":"Wells G. Wells G.A., Shea B., O'Connell D., Peterson J., Welch V., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses In. 2011."},{"issue":"9","key":"10.1016\/j.jiph.2025.102711_bib13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/378807","article-title":"A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome","volume":"37","author":"Benson","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2025.102711_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00002030-199703110-00008","article-title":"Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection","volume":"11","author":"Chaisson","year":"1997","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.jiph.2025.102711_bib15","first-page":"1225","article-title":"A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy","volume":"176","author":"Dub\u00e9","year":"1997","journal-title":"Calif Collab Treat Group J Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s100960050220","article-title":"Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients","volume":"18","author":"Fournier","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2025.102711_bib17","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/514748","article-title":"A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex","volume":"28","author":"Gordin","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2025.102711_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1086\/513753","article-title":"Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium","volume":"25","author":"May","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1513\/AnnalsATS.201308-266OC","article-title":"Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study","volume":"11","author":"Miwa","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.jiph.2025.102711_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jiac.2017.01.007","article-title":"The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: a nationwide post-marketing study","volume":"23","author":"Kadota","year":"2017","journal-title":"J Infect Chemother"},{"issue":"12","key":"10.1016\/j.jiph.2025.102711_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1258\/0956462991913565","article-title":"A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection","volume":"10","author":"Keiser","year":"1999","journal-title":"Int J STD AIDS"},{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-019-0982-8","article-title":"Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jiph.2025.102711_bib23","doi-asserted-by":"crossref","unstructured":"Gail L. Woods B.A.B.-E., Patricia S. Conville, Edward P. Desmond, Geraldine S. Hall, et al. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes, 2nd edition 2011 [Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544374\/?report=classic\u3009.","DOI":"10.1128\/9781555816728.ch73"},{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1086\/520141","article-title":"A prospective randomized trial of four three-drug regimens in the treatment of disseminated mycobacterium avium complex disease in aids patients: excess mortality associated with high-dose clarithromycin","volume":"29","author":"Cohn","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102711_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jac\/dkae041","article-title":"Why do we use 100\u2005mg of clofazimine in TB and NTM treatment?","volume":"79","author":"van Ingen","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2025.102711_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.638306","article-title":"Role of clofazimine in treatment of Mycobacterium avium complex","volume":"8","author":"Nasiri","year":"2021","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.jiph.2025.102711_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02035-17","article-title":"Antibiotic susceptibility and genotyping of Mycobacterium avium strains that cause pulmonary and disseminated infection","volume":"62","author":"Uchiya","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1258-9","article-title":"Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis","volume":"20","author":"Park","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jiph.2025.102711_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107366","article-title":"Monotherapy: key cause of macrolide-resistant Mycobacterium avium complex disease","volume":"217","author":"Loewenstein","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.jiph.2025.102711_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106025","article-title":"Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy","volume":"169","author":"Ito","year":"2020","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01787-19","article-title":"Intermittent treatment with azithromycin and ethambutol for noncavitary Mycobacterium avium complex pulmonary disease","volume":"64","author":"Moon","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jiph.2025.102711_bib32","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.01355-09","article-title":"Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular mycobacterium avium","volume":"54","author":"Deshpande","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jiph.2025.102711_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/WNO.0b013e3182901969","article-title":"Drug-related mitochondrial optic neuropathies","volume":"33","author":"Wang","year":"2013","journal-title":"J Neuroophthalmol"},{"issue":"55","key":"10.1016\/j.jiph.2025.102711_bib34","first-page":"4412","article-title":"Ethambutol induced bullous and lichenoid skin eruptions","volume":"38","author":"In\u00e9s","year":"2011","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.jiph.2025.102711_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.201204-0682OC","article-title":"The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment","volume":"186","author":"van Ingen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jiph.2025.102711_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00874-23","article-title":"The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease","volume":"67","author":"Schildkraut","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.jiph.2025.102711_bib37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/106002809502901114","article-title":"Rifabutin-associated uveitis","volume":"29","author":"Tseng","year":"1995","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.jiph.2025.102711_bib38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/clinids\/21.3.594","article-title":"Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease","volume":"21","author":"Griffith","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102711_bib39","unstructured":"Winthrop K.L. Comparison of two- versus three-antibiotic therapy for pulmonary Mycobacterium avium complex disease."},{"issue":"1","key":"10.1016\/j.jiph.2025.102711_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40780-015-0029-0","article-title":"Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes","volume":"1","author":"Shimomura","year":"2015","journal-title":"J Pharm Health Care Sci"},{"issue":"9","key":"10.1016\/j.jiph.2025.102711_bib41","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.21037\/jtd.2019.09.06","article-title":"Effect of rifampicin and clarithromycin on the CYP3A activity in patients with Mycobacterium avium complex","volume":"11","author":"Akiyama","year":"2019","journal-title":"J Thorac Dis"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:38:19Z","timestamp":1744493899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1876034125000607"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102711","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102711"}}